Stay up to date with everything Adastra and the cannabis industry

May 29, 2020 – Adastra Labs Inc. (CSE: XTRX) (FRANKFURT: D2EP) (“Adastra”), a  Health Canada Licensed cannabis processing and analytical testing services Company, announces, further to Adastra’s April 24, 2020 news release in relation to the timing of the filing of its year-end financial statements, the corporation now expects to file such documents on or prior

May 22nd, 2020 – Adastra Labs Inc. (CSE: XTRX) (FRANKFURT: D2EP) (“Adastra”) a  Health Canada Licensed cannabis processing and analytical testing services Company, is pleased to announce the receipt of its initial purchase order for bulk distillate from CannMart  Inc. (“CannMart”) a majority owned subsidiary of Namaste Technologies Inc. (“Namaste”) (TSX-V: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF). “We

April 29, 2020 – Adastra Labs Inc. (CSE: XTRX) (FRANKFURT: D2EP) (“Adastra” or the “Company”) announces the appointment of Kyle J. Boniface as Director of Production.

  LANGLEY, BC / ACCESSWIRE / April 24, 2020 / Adastra Labs Inc. (CSE:XTRX)(FRANKFURT:D2EP) (“Adastra” or the “Company”) as a result of the COVID-19 pandemic, will be relying on the coordinated relief provided by the securities regulators, which consists of a 45-day extension for certain periodic filings, as announced by the Canadian Securities Administrators (CSA)

LANGLEY, BC / ACCESSWIRE / April 23, 2020 /Adastra Labs Inc. (CSE:XTRX)(FRANKFURT:D2EP) (“Adastra”) a provider of same-site Health Canada Licensed cannabis processing and analytical testing services, is pleased to announce the completion of Commissioning and Commencement of Operations “We are pleased to announce the completion of an extensive and rigorous commissioning program that has proven